Avedro
Medical device and pharmaceutical company advancing the science and technology of corneal cross-linking.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD136—205m (Dealroom.co estimates May 2018.)
Waltham Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$8.0m | Series A | ||
$10.0m | Series B | ||
N/A | $6.3m | Early VC | |
N/A | $13.0m | Early VC | |
$25.0m | Series C | ||
N/A | $500k | Early VC | |
$43.0m | Series D | ||
N/A | $13.7m | Debt | |
$32.0m | Series E | ||
$42.0m | Early VC | ||
$25.0m | Series F | ||
N/A | N/A | IPO | |
Total Funding | CAD279m |
Related Content
Recent News about Avedro
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.